Target intelligence / Profile preview

Histone-like protein (HU)

Target
HU
Molecular classification
Nucleoid-associated protein, DNA-binding protein, Transcription factor, Architectural protein
01

Overview

Histone-like proteins, primarily represented by the HU (Heat-unstable) protein family, are small, basic, DNA-binding proteins that serve as the primary architectural components of the bacterial nucleoid. They are functional analogs to eukaryotic histones, responsible for compacting the bacterial chromosome through DNA bending, wrapping, and the induction of negative supercoiling. Beyond their structural role, these proteins act as global transcriptional regulators that modulate the expression of genes essential for virulence, metabolism, and adaptation to environmental stress. In many pathogenic species, such as Mycobacterium tuberculosis and Vibrio cholerae, histone-like proteins are indispensable for survival and the development of drug-tolerant subpopulations. Additionally, they are critical for the integrity of biofilms, where they stabilize the lattice of extracellular DNA (eDNA) within the matrix. Therapeutic approaches currently under investigation include monoclonal antibodies that disrupt biofilm structures and small-molecule inhibitors that target the protein's DNA-binding or dimerization interfaces. Because these proteins are structurally distinct from human histones, they are considered high-value targets for the development of novel, narrow-spectrum antimicrobial therapies.

Other names
Heat-unstable proteinNucleoid-associated proteinDNABII family proteinHistone-like nucleoid-structuring proteinH-NSIntegration host factorIHFFactor for inversion stimulationFisHlpAHBsuHupBLsr2
02

Mechanism of action

Inhibition of DNA binding, disruption of protein dimerization, perturbation of nucleoid architecture, and destabilization of the extracellular biofilm matrix.

03

Biological functions

DNA compactionNucleoid organizationRegulation of transcriptionDNA replication initiationGenetic recombinationDNA repairBiofilm structural stabilizationStress response regulation
04

Disease associations

InfectionBiofilm-associated diseaseTuberculosisSepsisCystic fibrosis-associated infectionOtitis media
05

Safety considerations

Potential cross-reactivity with eukaryotic histonesRisk of derepressing multidrug efflux pumps (e.g., AcrEF, MdtEF)Toxicity from rapid biofilm collapse and endotoxin releaseTherapeutic resistance through compensation by other nucleoid-associated proteins
06

Interacting drugs

HuTipMab

6 more in the full profile.

07

Biomarkers

HU protein levels in biofilmNucleoid morphologyiniBAC operon expressionExtracellular DNA (eDNA) concentration

Beyond the preview

Go deeper on Histone-like protein (HU).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone-like protein (HU).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call